Lam Research Corporation

NASDAQ:LRCX

Semiconductors

Technology
$211.67 +5.26%

+$19.70 today

Market cap
$264.41B
Beta
1.87
P/E (TTM)
73.4
EPS (TTM)
$5.37
Dividend yield
0.26%
52W Low $87.75High $401.00

Volume 7.61M

Average 11.84M

LRCX EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Lam Research CorporationNASDAQ: LRCX

EBITDA · Q1 FY2027 · quarter ended Sep 2026

EBITDA growth accelerates

Q1 FY2027 EBITDA of $3.43B rose 75.1% year over year, ahead of the +45.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 32.5% from the prior quarter. Over 3 fiscal years it compounded at +15.6% a year.

Context

  • EBITDA amounted to 37.5% of revenue in FY2026, up 3.1 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 24 analysts of $14.34B (+64.8%) for the fiscal year ending Jun 2027, a step up from the +37.2% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$3.43B+32.5% QoQ
Last fiscal yearJun 2026
$8.7B+37.2% YoY
LTMSep 2026
$10.18B+45.2% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+75.1%+74.7%-0.4 pp
1 year+37.2%+64.8%+27.6 pp
3-year CAGR+15.6%+34.3%+18.7 pp
5-year CAGR+26.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
8.7B USD
Year-over-year change
+37.2%
4-year CAGR
+11.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How LRCX compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +45.2% is the highest of 6, against a peer median of +15.3%.
  • EBITDA amounts to 38.9% of revenue for LRCX, versus a peer median of 35.9%.
LRCX Competitors
EBITDA for LRCX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ASMLASML Holding N.V.LTM Sep 2026€16.4B EUR+32.1%+20.5%41.5%
AMATApplied Materials, Inc.LTM Oct 2026$12.38B USD+24.2%+13.6%35.9%
LRCXLam Research CorporationLTM Sep 2026$10.18B USD+45.2%+15.6%38.9%
KLACKLA CorporationLTM Jun 2026$6.05B USD+13.4%+10.4%44.6%
ACMRACM Research, Inc.LTM Sep 2026$219.7M USD+15.3%+28.7%19.3%
VECOVeeco Instruments Inc.LTM Sep 2026$43.58M USD-41.6%-8.0%6.0%
Peer median (excluding LRCX) —+15.3%+13.6%35.9%

Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue17.23B17.43B14.91B18.44B23.23B
Cost of Revenue9.36B9.65B7.85B9.46B11.51B
Gross Profit7.87B7.78B7.05B8.98B11.73B
Gross Margin45.7%44.6%47.3%48.7%50.5%
Research & Development1.6B1.73B1.9B2.1B2.38B
Selling, General & Admin885.74M832.75M868.25M981.7M1.15B
Operating Expenses2.49B2.6B2.79B3.08B3.53B
Depreciation & Amortization333.74M342.43M359.7M386.28M441.53M
EBITDA5.71B5.64B4.91B6.34B8.7B
EBITDA Margin33.2%32.4%32.9%34.4%37.5%
Operating Income5.38B5.17B4.26B5.9B8.2B
Operating Margin31.2%29.7%28.6%32.0%35.3%
Interest Income15.21M138.98M251.94M231.33M0
Interest Expense184.76M186.46M185.24M178.2M0
Other Income / Expenses(188.71M)(65.65M)96.31M57.16M62.68M
Income Before Tax5.19B5.11B4.36B5.96B8.26B
Pre-Tax Margin30.1%29.3%29.3%32.3%35.6%
Income Tax Expense587.83M598.28M532.45M599.91M997.08M
Net Income4.61B4.51B3.83B5.36B7.27B
Net Margin26.7%25.9%25.7%29.1%31.3%
EPS (Basic)3.293.332.914.175.79
EPS (Diluted)3.273.322.904.155.76
Weighted Avg Shares1.4B1.35B1.31B1.29B1.26B
Weighted Avg Shares (Diluted)1.41B1.36B1.32B1.29B1.26B

Lam Research Corporation

NASDAQ:LRCX

Intrinsic Alpha fair value

Locked

Current Price

$211.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.